Login to Your Account

ABPI Eschews Trial Data

UK Turns to Real-World Data To Bolster Drug Reimbursement

By Nuala Moran

Wednesday, October 12, 2011
LONDON – The UK biopharmaceutical industry is preparing a new defense against the incursions that health technology assessments (HTA) are making on its ability to get reimbursement for some drugs and the full price for others, turning to real-world data to demonstrate the value of its products. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription